Suppr超能文献

黄斑下出血:印度人群中的一项研究。

Submacular hemorrhage: a study amongst Indian eyes.

机构信息

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.

出版信息

Indian J Ophthalmol. 2012 Nov-Dec;60(6):521-5. doi: 10.4103/0301-4738.103779.

Abstract

AIM

To evaluate the management outcomes amongst various treatment modalities for submacular hemorrhage (SMH) in Indian subjects.

SETTINGS AND DESIGN

Retrospective, single-center study.

MATERIALS AND METHODS

Patients presenting with SMH between 1999 and 2006 were included. Treatment modalities included: vitrectomy with subretinal recombinant tissue plasminogen activator (r-tPA) assisted SMH evacuation (group 1, n = 14); pneumatic displacement with intravitreal r-tPA and gas (group 2, n = 25); and pneumatic displacement with intraocular gas (group 3, n = 7). Favorable anatomical outcome was defined as complete displacement of SMH from fovea and favorable functional outcome was defined as a gain of >2 Snellen lines from the baseline. Kruskal-Wallis, analysis of variance (ANOVA), and Chi-square tests were used to compare the three groups, while Mann-Whitney and independent t-test were used to evaluate the influence of duration and size of SMH on outcomes.

RESULTS

There was no difference amongst groups in terms of favorable anatomical (P = 0.121) or functional outcomes (P = 0.611). Eyes with median duration of SMH less than 7.5 days had a significantly higher probability of achieving favorable anatomical outcome compared to eyes with SMH >14.5 days (P = 0.042). However, duration of SMH did not influence functional outcome (P = 0.595). Similarly, size of SMH did not affect anatomical (P = 0.578) or functional (P = 0.381) outcome. Median follow-up was 31.5, 6.5, and 2.5 months in the three groups, respectively.

CONCLUSIONS

Co- existing posterior segment conditions and duration of SMH may influence the choice of treatment modality and treatment outcomes. Pneumatic displacement with r-tPA and r-tPA assisted vitrectomy appear to be favorable options for the management of SMH.

摘要

目的

评估印度患者中不同治疗方法对黄斑下出血(SMH)的管理结果。

设置和设计

回顾性单中心研究。

材料和方法

纳入 1999 年至 2006 年间出现 SMH 的患者。治疗方法包括:视网膜下重组组织纤溶酶原激活剂(r-tPA)辅助黄斑下出血切除术(第 1 组,n = 14);玻璃体内 r-tPA 和气体的气动移位(第 2 组,n = 25);以及眼内气体的气动移位(第 3 组,n = 7)。理想的解剖学结果定义为黄斑下出血完全从黄斑移位,理想的功能结果定义为与基线相比增加>2 Snellen 行。使用 Kruskal-Wallis、方差分析(ANOVA)和卡方检验比较三组,使用 Mann-Whitney 和独立 t 检验评估 SMH 的持续时间和大小对结果的影响。

结果

三组在理想的解剖学(P = 0.121)或功能结果(P = 0.611)方面没有差异。SMH 持续时间中位数<7.5 天的眼睛与 SMH>14.5 天的眼睛相比,实现理想解剖学结果的可能性明显更高(P = 0.042)。然而,SMH 的持续时间并不影响功能结果(P = 0.595)。同样,SMH 的大小也不影响解剖学(P = 0.578)或功能(P = 0.381)结果。三组的中位随访时间分别为 31.5、6.5 和 2.5 个月。

结论

共存的后节条件和 SMH 的持续时间可能影响治疗方法的选择和治疗结果。r-tPA 和 r-tPA 辅助玻璃体切除术的气动移位似乎是治疗 SMH 的有利选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9ac/3545128/a7de4d8193fd/IJO-60-521-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验